Company: SNPS
Filing Date: 2025-02-14
Form Type: DEF 14A
Source: 0000883241-25-000008
Chunk: 109

Company: SYNOPSYS INC
Filing Date: 2025-02-14
Form: DEF 14A
Chunk 109
---
           |
| Sassine Ghazi          |     | 1,260,000 |                            |                                   | 1,680,000 |     | 42,101 |                    |                    | 9,236,333 |     |                    | 1,645,505 |
| Dr. Aart J. de Geus(3) |     |         — |                            |                                   |         — |     |      — |                    |                    |         — |     |                    |         — |
| Shelagh Glaser         |     |   600,000 |                            |                                   |   600,000 |     | 28,052 |                    |                    | 6,105,715 |     |                    |   640,069 |
| Rick Mahoney           |     |   450,000 |                            |                                   |   675,000 |     | 20,633 |                    |                    | 4,559,328 |     |                    |   782,869 |
| John F. Runkel, Jr.    |     |   450,000 |                            |                                   |   360,000 |     | 28,052 |                    |                    | 3,408,998 |     |                    |   381,846 |

(1) Amounts represent the cash-based incentive award that would be received under the EIP assuming (i) the average achievement of our Corporate Financial Goals is equal to 100.0% and, for Messrs. Mahoney and Runkel and Ms. Glaser, (ii) 12 months served as a full-time employee during the applicable period.

(2) Amounts represent the intrinsic value of accelerated restricted stock units and stock options based upon $518.40, the closing price per share of our common stock on November 1, 2024, the last trading day of fiscal 2024, as reported on the Nasdaq Global Select Market. The amounts in the column "Intrinsic Value of Unvested RSU Awards" assumes the vesting of the remaining 2022 Annual PRSUs scheduled to vest on December 8, 2024. See footnote 7 to the table "Outstanding Equity Awards at Fiscal 2024 Year-End" on page 87for more information.

(3) Dr. de Geus is not entitled to receive severance on account of terminations of employment occurring more than 90 days before, or more than 24 months following,